Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06811389 · ClinicalTrials.gov registry record · NA

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

A NA study of Hypersensitivity Pneumonitis, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06811389 is a NA study of Hypersensitivity Pneumonitis that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 389-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06811389, a NA study of Hypersensitivity Pneumonitis, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educational intervention, RISE-HP, is to improve health-related quality of life in people who have hypersensitivity pneumonitis and assess feasibility and accessibility of this intervention. Patients with hypersensitivity pneumonitis (HP) experience uncertainty, feelings of anxiety and depression, and marked disruption to their lifestyle and home environment. Poor health-related quality of life (HRQOL) in HP is also driven in part by patients' profound lack of knowledge about the disease. Existing interventions for patients with HP do not target improvement in quality of life. Participants will complete either RISE-HP, a 10-session peer coach delivered behavioral and educational intervention to improve HRQOL in HP, or Staying Well, a 10-session general health education program.

Interventions

  • BEHAVIORAL Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)
  • BEHAVIORAL Staying Well

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-05-06
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT06811389

The ClinicalTrials.gov registry entry for NCT06811389 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 389-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (90% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypersensitivity Pneumonitis appearing as the primary indexed condition, and to 2 interventions - of which Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP) is the first listed.

NCT06811389 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06811389 about?

NCT06811389 is a clinical study titled "Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis". The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educa...

What is the current status of trial NCT06811389?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-05-06. Estimated completion is 2026-12.

What conditions does trial NCT06811389 study?

This clinical trial studies the following conditions: Hypersensitivity Pneumonitis.

What interventions are being tested in trial NCT06811389?

The interventions under investigation include: Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP) (BEHAVIORAL), Staying Well (BEHAVIORAL).

Who is sponsoring clinical trial NCT06811389?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06811389 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypersensitivity Pneumonitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.